Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience
NCT02557750
·
clinicaltrials.gov ↗
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Hepatoblastoma
Sponsor
Assiut University